AIC
CPHI icon

Ameritas Investment Company’s China Pharma Holdings CPHI Stock Holding History

Ameritas Investment Company’s Portfolio CPHI Stock Details CPHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-8
Closed -$1K – 1120
2018
Q4 		$1K Buy
+8
New +$1.16K ﹤0.01% 1418

Other funds holding CPHI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameritas Investment Company's CPHI Position: Q1 2019 in Review

Ameritas Investment Company sold out of China Pharma Holdings (CPHI) in Q1 2019, closing a stake of 8 shares — an estimated $1K sold.

Ameritas Investment Company first reported a position in CPHI in Q4 2018 and held it in 1 quarter. The position peaked at $1K in Q4 2018. 5 funds tracked by Wall St. Rank hold CPHI as of Q1 2019.

  • Ameritas Investment Company reported no remaining China Pharma Holdings position as of Q1 2019 after selling out during the quarter.
  • Ameritas Investment Company sold 8 China Pharma Holdings shares in Q1 2019, an estimated $1K.
  • Ameritas Investment Company first reported a position in China Pharma Holdings in Q4 2018 and held it in 1 quarter.
  • Ameritas Investment Company's China Pharma Holdings position peaked at $1K in Q4 2018.
  • 5 funds tracked by Wall St. Rank held China Pharma Holdings as of Q1 2019.

Based on Ameritas Investment Company's 13F filing for Q1 2019, filed 16 May 2019.